동물용 백신 시장 : 동물 유형별, 기술별, 투여 경로별, 유통 채널별, 지역별

Veterinary Vaccines Market is estimated to be valued at USD 11.30 Bn in 2026 and is expected to reach USD 19.36 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.0% from 2026 to 2033.

Veterinary vaccines are biological preparations administered to animals in order to stimulate the immune system and provide active immunity against a disease. Vaccination protects individual animals from infectious diseases and generates herd immunity which indirectly protects the whole community. The global veterinary vaccine market has shown rapid expansion over the past few decades driven by the increasing awareness about animal healthcare as pets have become an integral part of people's families. Government mandates in various countries have also encouraged vaccination of livestock and companion animals. Advancements in vaccination technologies and recombinant procedures have enabled manufacturers to develop efficacious vaccines against a wide range of zoonotic diseases.

Market Dynamics

The global veterinary vaccine market is driven by factors such as rising pet adoption, growing animal healthcare expenditure, government initiatives for animal disease control, increase in the risk of zoonotic diseases, and intensification of livestock farming. However, high cost of vaccine production, stringent regulations and lack of necessary infrastructure and expertise in some regions constrain market growth. Advancements in delivery systems, therapeutic approaches, and epitope mapping offer opportunities in the veterinary vaccines market. Pharmaceutical companies are developing recombinant protein and antitoxins for effective vaccination against swine fever, bird flu, rabies, and bovine tuberculosis which are major threats to animals as well as public health. Introduction of single-dose formulations and integrated needle-free injectors aim to reduce vaccination costs and improve convenience.

Key Features of the Study

• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global veterinary vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Aratana Therapeutics Inc., Regeneus Ltd., Morphogenesis Inc., Karyopharm Therapeutics Inc., Zoetis Inc., Eli Lilly and Company, Merck & Co. Inc., Boehringer Ingelheim GmbH., Elanco Animal Health, Virbac, Hester Biosciences Limited, Ceva Sante Animale, Phibro Animal Health Corporation, Kemin Industries, Inc., Finlab, Vaxxinova , Vira Vaccine Shaya, and VETERQUIMICA SA.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global veterinary vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary vaccines market.

Market Segmentation

• Animal Type Insights (Revenue, USD Bn, 2026 - 2033)
• Companion
  • Equine
  • Canine
  • Feline
• Livestock
  • Bovine
  • Ovine
  • Porcine
  • Poultry
  • Others
• Technology Insights (Revenue, USD Bn, 2026 - 2033)
• Inactivated Vaccines
• Toxoid Vaccines
• Live Attenuated Vaccines
• Subunit and DNA Vaccines
• Recombinant Vaccines
• Route of Administration Insights (Revenue, USD Bn, 2026 - 2033)
• Subcutaneous Injection
• Intramuscular Injection
• Intranasal Administration
• Others
• Distribution Channel Insights (Revenue, USD Bn, 2026 - 2033)
• Public
• Private
• Regional Insights (Revenue, USD Bn, 2026 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Aratana Therapeutics Inc.
• Regeneus Ltd.
• Morphogenesis Inc.
• Karyopharm Therapeutics Inc.
• Zoetis Inc.
• Eli Lilly and Company
• Merck & Co. Inc.
• Boehringer Ingelheim GmbH.
• Elanco Animal Health
• Virbac
• Hester Biosciences Limited
• Ceva Sante Animale
• Phibro Animal Health Corporation
• Kemin Industries, Inc.
• Finlab
• Vaxxinova
• Vira Vaccine Shaya
• VETERQUIMICA SA

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Technology
  • Market Snapshot, By Animal Type
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• PEST Analysis

4. Global Veterinary Vaccine Market, By Technology, 2026 - 2033, (US$ Billion)

• Overview
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Inactivated Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
• Toxoid Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
• Live Attenuated Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
• Subunit and DNA Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
• Recombinant Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

5. Global Veterinary Vaccine Market, By Animal Type, 2026 - 2033, (US$ Billion)

• Overview
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Companion
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
    • Equine
    • Canine
    • Feline
• Livestock
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
    • Bovine
    • Ovine
    • Porcine
    • Poultry
    • Others

6. Global Veterinary Vaccine Market, By Route of Administration, 2026 - 2033, (US$ Billion)

• Overview
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Subcutaneous Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
• Intramuscular Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
• Intranasal Administration
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

7. Global Veterinary Vaccine Market, By Distribution Channel, 2026 - 2033, (US$ Billion)

• Overview
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Public
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
• Private
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

8. Global Veterinary Vaccine Market, By Region, 2026 - 2033, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2026-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (US$ Billion)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Aratana Therapeutics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Regeneus Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Morphogenesis, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Karyopharm Therapeutics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Zoetis, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Eli Lilly and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Boehringer Ingelheim GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact